Patents Assigned to Jenner Biotherapies, Inc.
  • Patent number: 6110492
    Abstract: A composition which comprises a stable oil-in-water emulsion having a continuous water phase and a discontinuous oil phase and containing, as sole stabilizing agent, a sufficient quantity of smectic mesophase vesicles and their disintegrated forms to provide at least about 100 mM amphiphile is stable and useful as an adjuvant, in a vaccine, or drug delivery system
    Type: Grant
    Filed: May 28, 1998
    Date of Patent: August 29, 2000
    Assignee: Jenner Biotherapies, Inc.
    Inventors: Carl R. Alving, Jean M. Muderhwa, Lynn E. Spitler